help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 58, No. 1 197-200
doi:10.1210/jcem-58-1-197
Copyright © 1984 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BOROWSKI, G. D.
Right arrow Articles by LEVY, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BOROWSKI, G. D.
Right arrow Articles by LEVY, R. A.

Blood Pressure Response to Thyrotropin-Releasing Hormone in Euthyroid Subjects

GREGORY D. BOROWSKI, CATHERINE D. GAROFANO, LESLIE I. ROSE and RICHARD A. LEVY

Department of Medicine, Division of Endocrinology and Metabolism, Hahnemann University School of Medicine Philadelphia, Pennsylvania 19012

Address requests for reprints to: Leslie I. Rose, M.D., Division of Endocrinology and Metabolism, Hahnemann University School of Medicine, 230 North Broad Street, Philadelphia, Pennsylvania 19102.

The iv administration of TRH has been associated with side effects, such as nausea, flushing, and urinary urgency. However, few reports mention changes in blood pressure. This study defines the mean and range of the blood pressure responses in 70 euthyroid patients subjected to iv administered TRH. The mean increase was 21.0 ± 1.4 mm Hg for systolic and 13.9 ± 1.0 mm Hg for diastolic blood pressure; however, individual peak values increased as much as 56 and 42 mm Hg, respectively. Thus, the hemodynamic response to iv administered TRH can be quite severe in some subjects, and caution is suggested in selecting patients for testing.

Received May 13, 1983.




This article has been cited by other articles:


Home page
J Intensive Care MedHome page
R. N. Nawar, D. AbdelMannan, W. R. Selman, and B. M. Arafah
Analytic Review: Pituitary Tumor Apoplexy: A Review
J Intensive Care Med, March 1, 2008; 23(2): 75 - 90.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
M. B. Stein and T. W. Uhde
Endocrine, Cardiovascular, and Behavioral Effects of Intravenous Protirelin in Patients With Panic Disorder
Arch Gen Psychiatry, February 1, 1991; 48(2): 148 - 156.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1984 by The Endocrine Society